Crystal Adam bought TNGX
May 1, 2026 · Form 4 insider transaction
Crystal Adam bought 27,000 shares of Tango Therapeutics, Inc. at $5.20 per share, a transaction worth $140.4K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
27,000
Price
$5.20
Total value
$140.4K
InsiderCrystal Adam
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMay 1, 2026
Filing dateMay 5, 2026
Shares owned after142,743
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on October 27, 2025.; Includes 3,121 shares that were acquired on November 1, 2025 pursuant to the Tango Therapeutics, Inc. 2021 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).